Effects of intelligent nursing and transfusion system on transfusion management in patients with growth hormone adenoma complicated with cardiomyopathy
10.3760/cma.j.issn.1674-2907.2019.30.007
- VernacularTitle:智慧护理输液系统在生长激素腺瘤合并心肌病患者输液管理中的应用
- Author:
Fei YAO
1
;
Jinglian LI
;
Xueling LI
;
Yanzhu FAN
Author Information
1. 首都医科大学附属北京天坛医院神经外科 100070
- Keywords:
Growth hormone adenoma;
Cardiomyopathy;
Venous transfusion;
Intelligent nursing and transfusion system;
Transfusion management;
Informatization
- From:
Chinese Journal of Modern Nursing
2019;25(30):3869-3872
- CountryChina
- Language:Chinese
-
Abstract:
Objective? To evaluate the effects of the intelligent nursing and transfusion system on transfusion management in patients with growth hormone adenoma complicated with cardiomyopathy. Methods? The patients with growth hormone adenoma complicated with cardiomyopathy treated in the Department of Neurosurgery in a ClassⅢ Grade A hospital from January 2018 to May 2019 were selected. Totally 78 patients receiving conventional transfusion management from January to October 2018 were included into the control group, while 70 patients admitted from November 2018 to May 2019 after the intelligent nursing and transfusion system was applied were included into the experimental group. The incidence rate of adverse effects in transfusion, correct rate of transfusion speed, incidence rate of arrhythmia and patients' compliant rate in terms of transfusion were evaluated between the two groups. Results? The incidence rate of adverse effects in transfusion in the experimental group was 5.7%, lower than 16.7% in the control group. The correct rate of transfusion speed was 97.0% in the experimental group, higher than 89.3% in the control group, and there was statistically significant difference between the two groups (P＜0.05). The incidence rates of arrhythmia in the experimental and control groups were 3.6% and 6.7%, respectively, and there was no statistically significant difference between the two groups (P＞0.05). The compliant rate about transfusion was 5.7% in the experimental group, lower than 16.7% in the control group, and there was statistically significant difference between the two groups (P＜ 0.05). Conclusions? The intelligent nursing and transfusion system can improve transfusion management in clinical practice, which not only reduce the incidence rate of adverse effects in transfusion and improve the transfusion safety in patients with growth hormone adenoma complicated with cardiomyopathy, and also reduce the compliant rate about transfusion and improve patients' satisfaction.
